These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid. Fàbregas A; Sánchez-Hernández N; Ticó JR; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Hernández-Munain C; Suñé C; Miñarro M Int J Pharm; 2014 Oct; 473(1-2):270-9. PubMed ID: 24999055 [TBL] [Abstract][Full Text] [Related]
3. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Vighi E; Ruozi B; Montanari M; Battini R; Leo E Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876 [TBL] [Abstract][Full Text] [Related]
4. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
5. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique. Negi JS; Chattopadhyay P; Sharma AK; Ram V Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618 [TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Liu J; Gong T; Wang C; Zhong Z; Zhang Z Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles. Kumar S; Randhawa JK Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026 [TBL] [Abstract][Full Text] [Related]
8. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design. Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Dehkordi AJ; Kobarfard F Pharm Dev Technol; 2012; 17(2):187-94. PubMed ID: 21047276 [TBL] [Abstract][Full Text] [Related]
9. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
10. Charge-mediated topical delivery of plasmid DNA with cationic lipid nanoparticles to the skin. Jin SE; Kim CK Colloids Surf B Biointerfaces; 2014 Apr; 116():582-90. PubMed ID: 24631964 [TBL] [Abstract][Full Text] [Related]
11. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511 [TBL] [Abstract][Full Text] [Related]
12. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818 [TBL] [Abstract][Full Text] [Related]
14. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Vighi E; Ruozi B; Montanari M; Battini R; Leo E Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555 [TBL] [Abstract][Full Text] [Related]
15. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
16. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. del Pozo-Rodríguez A; Solinís MA; Gascón AR; Pedraz JL Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256 [TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin. Wang T; Ma X; Lei Y; Luo Y Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376 [TBL] [Abstract][Full Text] [Related]
18. [PEI-PMMA cationic nanoparticles as carriers for gene transfer]. Feng M; Li P Yao Xue Xue Bao; 2005 Oct; 40(10):893-7. PubMed ID: 16408804 [TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123 [TBL] [Abstract][Full Text] [Related]
20. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Das S; Ng WK; Kanaujia P; Kim S; Tan RB Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]